NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Newsletters
Advertisement
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
HONcode
Security by Verisign

Human Papillomavirus


Return to Library

Free Human Papillomavirus Articles


New human papillomavirus research from G.Q. Xiao and colleagues discussed



2009 AUG 3 - (NewsRx.com) -- According to recent research published in the Australian & New Zealand Journal of Obstetrics & Gynaecology, "Like any screening method, Pap and HPV tests are subject to false negative results. We investigated the possible relationship between cervical parakeratosis/hyperkeratosis and a false negative result for both Pap and human papillomavirus (HPV) testing."

"A total of 551 cases with diagnostically adequate cervical biopsies and Pap tests performed concurrently were examined. The vast majority of the cases (75.5%) were of concordance in diagnosis. Among the 135 discordant diagnoses were 98 with low-grade squamous intraepithelial lesion (LSIL) biopsy and negative Pap test and 34 with negative biopsy and LSIL Pap test. With rare exceptions, no significant discordance between concurrent biopsy and Pap test was found in the cases of high-grade squamous intraepithelial lesion (HSIL). Cervical parakeratosis/hyperkeratosis was noted in 87.8% of the LSIL biopsies with concurrent negative Pap tests. An 83.3% HPV-negative rate was also observed in this group. By comparison, parakeratosis/hyperkeratosis was less frequent (62.6%) in the SIL biopsies with concordant concurrent SIL Pap tests and usually seen focally when present. The negative HPV rates for these concordant LSIL and HSIL groups were 12.7% and 0.0%, respectively," wrote G.Q. Xiao and colleagues.

The researchers concluded: "Cervical parakeratosis/hyperkeratosis is an important cause for the negative results of Pap and HPV tests in LSIL, and practising gynaecologist and pathologist should be aware of this possible diagnostic dilemma."

Xiao and colleagues published their study in Australian & New Zealand Journal of Obstetrics & Gynaecology (Cervical parakeratosis/hyperkeratosis as an important cause for false negative results of Pap smear and human papillomavirus test. Australian & New Zealand Journal of Obstetrics & Gynaecology, 2009;49(3):302-306).

For additional information, contact G.Q. Xiao, Mt Sinai Med Center, Dept. of Pathology, Box 1194, New York City, NY 10029, USA.

The publisher's contact information for the Australian & New Zealand Journal of Obstetrics & Gynaecology is: Wiley-Blackwell Publishing, Inc., Commerce Place, 350 Main St., Malden 02148, MA, USA.

Keywords: United States, Box, Biopsy, Diagnostics, Gynecology, HPV, Human Papillomavirus, Hyperkeratosis, Parakeratosis, Surgery.

This article was prepared by Gastroenterology Week editors from staff and other reports. Copyright 2009, Gastroenterology Week via NewsRx.com.

NewsRx NewsRx NewsRx
-----------------------
PR Login